MedPath

Decisionmaking for Abnormal Uterine Bleeding (AUB)

Not Applicable
Completed
Conditions
Abnormal Uterine Bleeding
Interventions
Other: Adaptive Conjoint Analysis
Registration Number
NCT01721304
Lead Sponsor
Indiana University
Brief Summary

The purpose of this study is to determine if using a computer survey about preferences for treatment of abnormal uterine bleeding (AUB) is useful and if it will improve patient satisfaction with clinical care and decision making. This study is a two-part study. The first pilot tests the computerized tool to ensure it is understood by patients, then the second part is a randomized study (computerized tool versus usual care) to see if improvements are made in satisfaction and if there are reductions in decision regret.

Detailed Description

The purpose of this study is to determine if using a computer survey about preferences for treatment of abnormal uterine bleeding (AUB) is useful and if it will improve patient satisfaction with clinical care and decision making. This study was designed to develop and test the use of ACA as part of routine clinical care for women diagnosed with AUB. After pilot testing, the ACA survey is administered in this study where patients are assigned to receive the ACA or to usual care.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
380
Inclusion Criteria
  • Have received a diagnosis of dysfunctional or abnormal uterine bleeding (AUB) that is recommended for treatment
  • Have not yet selected or initiated treatment for current AUB diagnosis
  • Be at least 18 years of age.
  • Be possible candidates for either medical or surgical therapy
  • Able to provide informed consent for treatment options for oneself
Exclusion Criteria
  • Are currently being treated for cancer
  • Any cancer diagnosis within the past 2 years (other than non-melanoma skin cancer)
  • AUB due to serious pelvic pathology, medications, pregnancy or systemic disease that limits their range of treatment options
  • Are not recommended for surgical intervention
  • Are not recommended for medical intervention
  • Are under 18 years of age
  • Have not received a diagnosis of AUB
  • Are currently being treated for AUB

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Adaptive Conjoint AnalysisAdaptive Conjoint AnalysisComputerized survey to elicit preferences
Primary Outcome Measures
NameTimeMethod
Differences in decision regret between treatment groups6 weeks

Decision regret is measured by the Decision Regret Scale

Differences in patient-reported satisfaction between treatment groups6 weeks

Satisfaction with care as measured by the Functional Assessment of Chronic Illness Therapy-Treatment Satisfaction-Patient Scale (FACT-TS-PS)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Indiana University

🇺🇸

Indianapolis, Indiana, United States

Southern Pines Women's Health Center

🇺🇸

Southern Pines, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath